by The BioPharma Team | Aug 3, 2020 | Bioanalysis, News, Phase 1
BioPharma Services INC. Successfully Completes 3 FDA Inspections With Zero Form 483s Toronto, Canada – BioPharma Services, Inc. (BioPharma) is proud to announce that it has successfully completed 3 inspections this month by the US FDA, with concurrent audits at both...
by The BioPharma Team | Aug 3, 2020 | Bioanalysis, News, Phase 1
BioPharma Services INC Completes Another Successful Inspection By The European Medicines Agency EMA Toronto, ON – Bio Pharma Services, Inc. (Bio Pharma) ended their 10th year anniversary celebrations by announcing the successful EMA inspection of their Toronto based...
by The BioPharma Team | Aug 3, 2020 | Bioanalysis, News, Phase 1
BioPharma Services INC. BPSI Announces 2016 Recipient Of Lorelei Lutter Scholarship BioPharma Services Inc. (BPSI) announces the 2016 recipient of the Lorelei Lutter Fine Arts Scholarship (LLFAS) in memory of Lorelei Lutter, VP Business Development. The scholarship is...
by The BioPharma Team | Aug 3, 2020 | Bioanalysis, News, Phase 1
BioPharma Services Acquires Key Assets from BLS Toronto, Canada – BioPharma Services, Inc. (BioPharma) is proud to announce that it has acquired key human resource assets along with a list of validated assays from Bioanalytical Laboratory Services (BLS). Over the past...
by The BioPharma Team | Aug 3, 2020 | Bioanalysis, News, Phase 1
BioPharma Services USA INC. Awarded 5 Year, $20M Contract With US FDA COLUMBIA, MO. (BUSINESS WIRE) BioPharma Services USA, Inc. (BioPharma) is proud to announce that it has been awarded a 5 year, $20 million contract with the Center for Drug Evaluation and...
by The BioPharma Team | Aug 3, 2020 | Bioanalysis, News, Phase 1
BioPharma Services INC. Successfully Completes ANVISA Inspection Toronto, ON – BioPharma Services Inc. (BioPharma) is proud to announce that its Toronto-based Bioanalytical Laboratory has successfully passed its first inspection by the Brazilian regulatory authority,...
Recent Comments